In VitroSUMO-1 Modification Requires Two Enzymatic Steps, E1 and E2
- 27 January 1999
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 254 (3), 693-698
- https://doi.org/10.1006/bbrc.1998.9995
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- SUMO-1 Modification of IκBα Inhibits NF-κB ActivationMolecular Cell, 1998
- A novel protein modification pathway related to the ubiquitin systemThe EMBO Journal, 1998
- A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex.The Journal of cell biology, 1996
- Associations of UBE2I with RAD52, UBL1, p53, and RAD51 Proteins in a Yeast Two-Hybrid SystemGenomics, 1996
- mUBC9, a Novel Adenovirus E1A-interacting Protein That Complements a Yeast Cell Cycle DefectPublished by Elsevier BV ,1996
- Differential Intrinsic Enzymatic Activity of Syk and Zap-70 Protein-tyrosine KinasesPublished by Elsevier BV ,1996
- Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizes in synaptonemal complexes.Proceedings of the National Academy of Sciences of the United States of America, 1996
- An Essential Yeast Gene Encoding a Homolog of Ubiquitin-activating EnzymeJournal of Biological Chemistry, 1995
- The ubiquitin-proteasome proteolytic pathwayCell, 1994
- Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1.Proceedings of the National Academy of Sciences of the United States of America, 1991